Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001982638-25-000004

Chief Commercial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Marshak Richard Chief Commercial Officer 2025-11-24 Grant or award +60,000 113,854 D
Derivatives
Marshak Richard Chief Commercial Officer 2025-11-24 Grant or award · Employee Stock Option (right to buy) +120,000 408,937 D
Loading xslF345X05/wk-form4_1764103333.xml…